Skip to content

Evaluation of an Intervention Program for the Prevention of Anemia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00436202
Enrollment
Unknown
Registered
2007-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2010-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia

Keywords

Anemia, Iron, Supplement

Brief summary

The purpose of the study is to determine whether improvement in the accessibility to iron supplement will decrease anemia rates in infants.

Detailed description

Iron deficiency anemia is the most common type of anemia in infants, children and women of reproductive age. The most frequent cause of iron deficiency in infants at 6 months of life is poor nutrition during a period of rapid growth and a diet lacking in iron rich foods. Children who suffered from anemia in infancy demonstrated slower cognitive development, were low achievers in school and had a high rate of behavioral disturbances. The Ministry of Health implements a primary prevention program for anemia. If by making iron supplements more accessible would increase parental compliance in acquisition of the iron supplement and subsequently reduce the rate of iron deficiency anemia, the result would be the immediate application of the finding. It is possible to implement a program whereby the supplement will be directly available at the family health centers for purchase by the parent.

Interventions

BEHAVIORALIron supplement

Sponsors

Tel Aviv District of the Health Office
CollaboratorUNKNOWN
Wolfson Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Months to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Infant who visit Family Health Centers

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026